Fabrication of heart tubes from iPSC derived cardiomyocytes and human fibrinogen by rotating mold technology

• Published in: Scientific reports 2024-06, Vol.14 (1), p.13174-14
• Main Authors: Andrée, Birgit, Voß, Nils, Kriedemann, Nils, Triebert, Wiebke, Teske, Jana, Mertens, Mira, Witte, Merlin, Szádocka, Sára, Hilfiker, Andres, Aper, Thomas, Gruh, Ina, Zweigerdt, Robert
• Format: Article
• Language: English
• Subjects: 631/532/2064; 631/61/2035; 692/699/75; Bioreactors; Cardiomyocytes; Cell Differentiation; Cells, Cultured; Fabrication; Fibrin; Fibrin - chemistry; Fibrin - metabolism; Fibrinogen; Fibrinogen - chemistry; Fibrinogen - metabolism; Fibrinolysis; Fibroblasts - metabolism; Heart; Humanities and Social Sciences; Humans; Induced Pluripotent Stem Cells - cytology; Induced Pluripotent Stem Cells - metabolism; multidisciplinary; Myocytes, Cardiac - cytology; Myocytes, Cardiac - metabolism; Pluripotency; Science; Science (multidisciplinary); Stem cells; Structure-function relationships; Tissue Engineering - methods; Tissue Scaffolds - chemistry; Translation
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-64022-7

Due to its structural and functional complexity the heart imposes immense physical, physiological and electromechanical challenges on the engineering of a biological replacement. Therefore, to come closer to clinical translation, the development of a simpler biological assist device is requested. Here, we demonstrate the fabrication of tubular cardiac constructs with substantial dimensions of 6 cm in length and 11 mm in diameter by combining human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and human foreskin fibroblast (hFFs) in human fibrin employing a rotating mold technology. By centrifugal forces employed in the process a cell-dense layer was generated enabling a timely functional coupling of iPSC-CMs demonstrated by a transgenic calcium sensor, rhythmic tissue contractions, and responsiveness to electrical pacing. Adjusting the degree of remodeling as a function of hFF-content and inhibition of fibrinolysis resulted in stable tissue integrity for up to 5 weeks. The rotating mold device developed in frame of this work enabled the production of tubes with clinically relevant dimensions of up to 10 cm in length and 22 mm in diameter which—in combination with advanced bioreactor technology for controlled production of functional iPSC-derivatives—paves the way towards the clinical translation of a biological cardiac assist device.